Erenumab Bests Topiramate in First Head-to-Head Migraine Trial Erenumab Bests Topiramate in First Head-to-Head Migraine Trial

The calcitonin-gene related peptide receptor inhibitor erenumab is more effective and tolerable than topiramate for treating migraine, new research suggests.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news